Nektar Says Eli Lilly Botched Autoimmune Drug Trials
Law 360
AUGUST 7, 2023
Nektar Therapeutics is accusing Eli Lilly of butchering and delaying clinical trials for a new autoimmune-disease drug the two companies agreed to develop together, claiming the pharma giant ruined the drug's prospects after it acquired a company with a competing drug.
Let's personalize your content